Konträr

<p>Study characteristics of included randomized trials of treatment of episodic (<15 headaches/month) migraine headaches.</p

Network meta-analysis

<p>Network meta-analysis</p

Quality Ratings of included placebo controlled trials.

<p>Quality Ratings of included placebo controlled trials.</p

ACE and ARBs compared to placebo for episodic migraine headaches.

<p>ACE and ARBs compared to placebo for episodic migraine headaches.</p

Comparative Effectiveness Trial Outcomes.

<p>δ negative number favors drug 1, positive number favors drug 2 in these comparisons.</p><p>Comparative Effectiveness Trial Outcomes.</p

TCAs compared to placebo for episodic migraine headaches.

<p>TCAs compared to placebo for episodic migraine headaches.</p

Characteristics of comparative effectiveness trials.

<p>Characteristics of comparative effectiveness trials.</p

Valproate compared to placebo for episodic migraine headaches.

<p>Valproate compared to placebo for episodic migraine headaches.</p

SSRI/SNRIs compared to placebo for episodic migraine headaches.

<p>SSRI/SNRIs compared to placebo for episodic migraine headaches.</p